These data emphasized the crucial role of ST6GAL1 and CYP19A1 in the pathogenesis of astrocytoma, and provide new biomarkers for the treatment and diagnosis of astrocytoma. The gene discussed is CYP19A1; the disease is astrocytoma (excluding glioblastoma).